Zalutsky M R, Venkatesan P P, English R J, Shortkroff S, Sledge C B, Adelstein S J
Int J Nucl Med Biol. 1986;12(6):457-65. doi: 10.1016/s0047-0740(86)80008-0.
The lymph node uptake of 165Dy was measured in 25 patients treated by radiation synovectomy via intra-articular injection of 165Dy-ferric hydroxide macroaggregates (FHMA). An average of 0.12% of the injected dose was found in the inguinal lymph nodes 19h post injection. This results in a lymph node of 16.6 rad (166 mGy), a dose significantly less than that reported following radiation synovectomy with other radiocolloids. Dosimetry calculations for the intra-articular injection of 165Dy-FHMA are provided in the appendix.
对25例通过关节腔内注射165镝-氢氧化铁大颗粒聚合体(FHMA)进行放射性滑膜切除治疗的患者,测量其淋巴结对165镝的摄取情况。注射后19小时,腹股沟淋巴结中平均发现注入剂量的0.12%。这导致淋巴结吸收剂量为16.6拉德(166毫戈瑞),该剂量显著低于使用其他放射性胶体进行放射性滑膜切除术后报告的剂量。附录中提供了关节腔内注射165镝-FHMA的剂量学计算。